Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites

Annals of Tropical Medicine and Parasitology

Volumn 100, Issue 1, 2006, Pages 33-38

  Najim, R A ^a   Sharquie, K E ^a   Al Zubaidy, S A A ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; HYPERTONIC SOLUTION; ISOTONIC SOLUTION; SODIUM CHLORIDE; STIBOGLUCONATE SODIUM; ZINC SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; EOSINOPHIL; ERYTHEMA; FEMALE; INFLAMMATORY CELL; INJECTION SITE; MALE; NONHUMAN; RABBIT; SKIN BIOPSY; SKIN LEISHMANIASIS; SKINFOLD THICKNESS;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CELL COUNT; EOSINOPHILS; ERYTHEMA; FEMALE; FIBROBLASTS; HUMANS; INJECTIONS, INTRALESIONAL; LEISHMANIASIS, CUTANEOUS; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; RABBITS; SALINE SOLUTION, HYPERTONIC; SKIN; ZINC SULFATE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 31344464344     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485906X78472     Document Type: Article

References (17)

1. 2 Laser Cautery. MSc thesis, College of Dentistry, University of Baghdad, Baghdad, Iraq.
2. Al-Mulla Hummadi, Y. M., Najim, R. A. & Al-Bashir, N.M. (2005). The mechanism behind the antileishmanial effect of zinc sulphate. I. An in-vitro study. Annals of Tropical Medicine and Parasitology, 99, 27-36.
3. Chehada, A. K. & Douba, M. E. D. (1990). Treatment of cutaneous leishmaniasis. Research Journal of Aleppo University, 19, 145-160.
4. Firooz, A., Khatami, A., Khameisipur, A., Nassiri-Khashani, M., Behnia, F., Niforushzadeh, M., Pazoki-Toroudi, H. & Dowlati, Y. (2005). Intralesional injection of 2% zinc sulfate solution in the treatment of acute Old World cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. Journal of Drugs in Dermatology, 4, 73-79.
5. Iraji, F., Vali, A., Asilian, A., Shahtalebi, M. A. & Momeni, A. Z. (2004). Comparison of intralesionaly injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology, 209, 46-49.
6. MacSween, R. N. M. & Whaley, K. (Eds) (1998). Muir's Textbook of Pathology, 13th Edn. New York, NY: Oxford University Press.
7. Sereno, D., Cavaleyra, M., Zemzourni, K., Maquaire, S., Ouaissi, A. & Lemesre, J. L. (1998). Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrobial Agents and Chemotherapy, 42, 3097-3102.
8. Sharquie, K. E. (1995). A new intralesional treatment of cutaneous leishmaniasis with hypertonic sodium chloride solution. Journal of Dermatology, 22, 732-737.
9. Sharquie, K. E. & Al-Azzawi, K. E. (1996). Intralesional therapy of cutaneous leishmaniasis with 2% zinc sulfate solution. Journal of the Pan Arab League of Dermatologists, 7, 41-46.
10. Sharquie, K. E. & Al-Nuaimi, A. A. (2002). Treatment of viral warts by intralesional injection of zinc sulphate. Annals of Saudi Medicine, 22, 26-28.
11. Sharquie, K. E., Al-Talib, K. & Chu, A. C. (1988). Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony. British Journal of Dermatology, 119, 53-57.
12. Sharquie, K. E., Najim, R. A. & Farjou, I. B. (1997). A comparative control trial of intralesional administered zinc sulfate, hypertonic saline chloride and PVA compound against cutaneous leishmaniasis. Clinical and Experimental Dermatology; 22, 169-173.
13. Sharquie, K. E., Al-Nuaimi, A. A. & Al-Shimary, F. A. (2005). New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution. Saudi Medical Journal, 26, 359-361
14. Tallab, T. M., Bahamdam, K. A., Mirdad, S., Johargi, H., Mourad, M. M., Ibrahim, K., El-Sherbini, A. H., Karkashan, E., Khare, A. K. & Jama, I. A. (1996). Cutaneous leishmaniasis: schedule for intralesional treatment with sodium stibogluconate. International Journal of Dermatology, 35, 594-597.
15. Uzan, S., Durdu, M., Cuhla, G., Allahverdiyev, A. M. & Memisoglu, H. R. (2004). Clinical features, epidemiology and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience from Turkey. Journal of Parasitology, 90, 853-859.
16. Webster Jr, L. T. (1985). Drugs used in chemotherapy of protozoa infections. In The Pharmacological Basis of Therapeutics, 7th Edn, eds Gilman, A., Goodman, L. S., Rail, T. W. & Murad, F. pp. 1029-1048. New York: MacMillan.
17. World Health Organization (1984). The Leishmaniasis: Report of a WHO Expert Committee. Technical Report Series No. 701. Geneva: WHO.